Reuters logo
BRIEF-U.S. FDA grants fast track designation to Pluristem's PLX-PAD for treating Critical Limb Ischemia
2017年9月18日 / 中午11点40分 / 3 个月前

BRIEF-U.S. FDA grants fast track designation to Pluristem's PLX-PAD for treating Critical Limb Ischemia

Sept 18 (Reuters) - Pluristem Therapeutics Inc

* U.S. FDA grants fast track designation to Pluristem’s PLX-PAD for the treatment of Critical Limb Ischemia (cli)

* Pluristem Therapeutics Inc - Pluristem’s ongoing phase III cli trial has been selected for accelerated approval pathways in both U.S. and Europe Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below